Register
Cart (0)

Home > Products > Assay Kits > Human sFlt-1 Kit

Contact an Account Manager

Human sFlt-1 Kit

Click image to enlarge

The Human sFlt-1 Kit provides assay-specific components for the quantitative determination of endogenous soluble fms-like tyrosine kinase-1 (sFlt-1, sVEGR1) in human serum, plasma, and tissue culture supernatant.

Specifications
Kit Contents
Documentation
References

Application(s)		Cardiovascular
Analyte(s)		VEGFR-1/Flt-1
Species		Human
Plate Type		96-well
Instrument(s)		MESO SECTOR S 600MM , MESO QuickPlex SQ 120MM , MESO SECTOR S 600 , MESO QuickPlex SQ 120 , SECTOR Imager 6000 , SECTOR Imager 2400
Capture Antibody		Mouse Monoclonal
Detection Antibody		Goat Polyclonal
LLOD (Sensitivity)		8.9 pg/mL
Dynamic Range		8.9-10000 pg/mL
Recombinant standards		Recombinant Human VEGF R1/Flt-1/Fc Chimera
Usage Statement		For Research Use Only. Not for use in diagnostic procedures.
Storage Statement(s)		Please refer to the product insert for the storage conditions of individual kit components.
Storage Condition		Multi-Component

Kit Contents for Catalog No. K151EJC-1

Product Description	Storage	Quantity per Kit
Human sFlt-1 Calibrator	≤-70 °C	1 vial (30 μL)

SULFO-TAG Anti-human Flt-1 Antibody	2-8 °C	1 vial (40 μL)

Human sFlt-1 Plate	2-8 °C	1 each (1 each)

Diluent 8	≤-10 °C	1 each (5 mL)

Diluent 7	≤-10 °C	1 each (5 mL)

Diluent 9	≤-10 °C	1 each (10 mL)

Read Buffer T 4X	RT	1 each (50 mL)

Blocker C, 100 mL	2-8 °C	1 each (100 mL)

Kit Contents for Catalog No. K151EJC-2

Product Description	Storage	Quantity per Kit
Human sFlt-1 Calibrator	≤-70 °C	5 vial (30 μL)

SULFO-TAG Anti-human Flt-1 Antibody	2-8 °C	1 vial (200 μL)

Human sFlt-1 Plate	2-8 °C	5 each (1 each)

Diluent 8	≤-10 °C	1 each (50 mL)

Diluent 7	≤-10 °C	1 each (50 mL)

Diluent 9	≤-10 °C	2 each (50 mL)

Read Buffer T 4X	RT	1 each (50 mL)

Blocker C, 100 mL	2-8 °C	1 each (100 mL)

Kit Contents for Catalog No. K151EJC-3

Product Description	Storage	Quantity per Kit
Human sFlt-1 Calibrator	≤-70 °C	20 vial (30 μL)

SULFO-TAG Anti-human Flt-1 Antibody	2-8 °C	4 vial (200 μL)

Human sFlt-1 Plate	2-8 °C	20 each (1 each)

Diluent 8	≤-10 °C	2 each (50 mL)

Diluent 7	≤-10 °C	2 each (50 mL)

Diluent 9	≤-10 °C	4 each (50 mL)

Read Buffer T 4X	RT	1 each (200 mL)

Blocker C, 1 LT	2-8 °C	1 each (1000 mL)

Order Details

K151EJC

Select your instrument:

S 600

SQ 120

Q 60

Catalog No

Size

Status

K151EJC-1

1 plate

K151EJC-2

5 plates

K151EJC-3

20 plates

Contact Information

Customer Service/Orders
1-240-314-2795

5:00 a.m. to 8:00 p.m.
US Eastern Time

Email

Scientific/Technical Support
1-240-314-2798

8:30 a.m. to 5:30 p.m.
US Eastern Time

Email

Instrument Support
1-301-947-2057

8:30 a.m. - 5:30 p.m.
US Eastern Time

Email

Company Headquarters
1-240-314-2600
1601 Research Blvd.
Rockville, Maryland 20850-3173
USA

Product Inserts		Human sFlt-1 Serum
SDS		Diluent 2, Diluent 3, Diluent 5, Diluent 7 and Diluent 8 MSD Calibrators and Controls Read Buffer T (4x), Read Buffer S (4x) and Read Buffer S (1x)

Title	Journal	Year
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study. Hirata S, Dirven L, Shen Y, Centola M, Cavet G, Lems WF, Tanaka Y, Huizinga TW, Allaart CF.	Rheumatology (Oxford)	2013
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2 in patients with advanced hepatocellular cancer. Zhu AX, Finn RS, Mulcahy M, Gurtler J, Sun W, Schwartz JD, Dalal RP, Joshi A, Hozak RR, Xu Y, Ancukiewicz M, Jain RK, Nugent F, Duda DG, Stuart K.	Clin Cancer Res.	2013
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Burmester GR, Weinblatt ME, McInnes IB, Porter D, Barbarash O, Vatutin M, Szombati I, Esfandiari E, Sleeman MA, Kane CD, Cavet G, Wang B, Godwood A, Magrini F; EARTH Study Group.	Ann Rheum Dis.	2013
Elevated sputum Interleukin-5 and submucosal eosinophilia in obese severe asthmatics. Desai D, Newby C, Symon FA, Haldar P, Shah S, Gupta S, Bafadhel M, Singapuri A, Siddiqui S, Woods J, Herath A, Anderson IK, Bradding P, Green R, Kulkarni N, Pavord I, Marshall RP, Sousa AR, May RD, Wardlaw AJ, Brightling CE.	Am J Respir Crit Care Med.	2013
Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea Doufas AG, Tian L, Padrez KA, Suwanprathes P, Cardell JA, Maecker HT, Panousis P.	PLoS One	2013
View All

Please Sign In

User name

Password

Human sFlt-1 Kit

Kit Contents for Catalog No. K151EJC-1

Kit Contents for Catalog No. K151EJC-2

Kit Contents for Catalog No. K151EJC-3

Order Details

K151EJC

S 600

SQ 120

Q 60

Top Products

Contact Information

Products

Services

Orders & Support

Key Topics